Foley partner David Rosen, co-chair of the firm’s FDA Practice Group is speaking in the Food and Drug Law Institute’s (FDLI) webinar titled “Hatch-Waxman at 40: A Critical Examination of its Past and Future” on September 24.
This webinar will celebrate the 40th anniversary of the Hatch-Waxman Act — an influential piece of legislation that has been crucial in advancing medical innovation and making generic drugs more accessible to patients.
People
Related Insights
26 September 2024
Events
Billing/Coding/Legal & Regulatory Update
Foley partner Rachel Goodman is speaking in the Kentucky Rural Telehealth Summit in a session titled “Billing/Coding/Legal & Regulatory Update” on September 23.
17 September 2024
Events
Evolutions in Telehealth: Federal Policy Updates and Key Considerations for Interacting with Telehealth Vendors
Foley partner Evan Hellman is speaking in Northeast Telehealth Resource Center’s 10th annual Regional Telehealth Conference in a session titled “Evolutions in Telehealth: Federal Policy Updates and Key Considerations for Interacting with Telehealth Vendors” on September 17.
10 September 2024
Alice Patent Eligibility Analysis Divergance Before USPTO and District Court
The Mayo/Alice framework for determining subject matter eligibility of patents under 35 U.S.C. §101 has long since antagonized both patent prosecutors and litigators alike, causing significant uncertainty in the realm of software-based technology and innovation.